RECOVERY Collaborative Group & Downey, D 2021, ' Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial ', Lancet (London, England), vol. 397, no. 10274, pp. 605-612 . https://doi.org/10.1016/S0140-6736(21)00149-5 LANCET Mumford, A, Ramanan, A V & Gibbison, B J J & Welch, H F 2021, ' Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY) : a randomised, controlled, open-label, platform trial ', Lancet, vol. 397, no. 10274, pp. 605-612 . https://doi.org/10.1016/S0140-6736(21)00149-5, https://doi.org/10.1016/S0140-6736(21)00149-5 The Lancet RECOVERY Collaborative Group, Felton, T, Evans, D G, Murray, C, Buch, M & Dark, P 2021, ' Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial ', Lancet (London, England), vol. 397, no. 10274, pp. 605-612 . https://doi.org/10.1016/S0140-6736(21)00149-5 2021, ' Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY) : a randomised, controlled, open-label, platform trial ', Lancet, vol. 397, no. 10274, pp. 605-612 . https://doi.org/10.1016/S0140-6736(21)00149-5
Nature Microbiology Seow, J, Graham, C, Merrick, B, Acors, S, Pickering, S, Steel, K J A, Hemmings, O, O’Byrne, A, Kouphou, N, Galao, R P, Betancor, G, Wilson, H D, Signell, A W, Winstone, H, Kerridge, C, Huettner, I, Jimenez-Guardeño, J M, Lista, M J, Temperton, N, Snell, L B, Bisnauthsing, K, Moore, A, Green, A, Martinez, L, Stokes, B, Honey, J, Izquierdo-Barras, A, Arbane, G, Patel, A, Tan, M K I, O’Connell, L, O’Hara, G, MacMahon, E, Douthwaite, S, Nebbia, G, Batra, R, Martinez-Nunez, R, Shankar-Hari, M, Edgeworth, J D, Neil, S J D, Malim, M H & Doores, K J 2020, ' Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans ', Nature Microbiology, vol. 5, no. 12, pp. 1598-1607 . https://doi.org/10.1038/s41564-020-00813-8 Nat Microbiol Nature microbiology, 5(12), 1598-1607. Nature Publishing Group
Europe PubMed Central Lancet (London, England) RECOVERY Collaborative Group & Downey, D 2022, ' Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial ', The Lancet, vol. 399, no. 10320, pp. 143-151 . https://doi.org/10.1016/S0140-6736(21)01825-0 Group, RECOVERY C & Dark, P 2022, ' Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. ', Lancet (London, England), vol. 399, no. 10320, pp. 143-151 . https://doi.org/10.1016/S0140-6736(21)01825-0 Mumford, A D 2022, ' Aspirin in patients admitted to hospital with COVID-19 (RECOVERY) : a randomised, controlled, open-label, platform trial ', Lancet, vol. 399, no. 10320, pp. 143-151 . https://doi.org/10.1016/S0140-6736(21)01825-0